News Resverlogix Corp.

Stocks

RVX

CA76128M1086

Biotechnology & Medical Research

Market Closed - Toronto S.E. 15:46:52 2026-09-04 EDT			5-day change	1st Jan Change
0.0950 ^CAD	-5.00%		0.00%	-5.00%

08-14	Resverlogix Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-25	Resverlogix Corp. - Shareholder/Analyst Call

All News

Mentions Relevance

08-14	Resverlogix Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-25	Resverlogix Announces Voting Results from the 2026 Meeting of Shareholders	NE
06-25	Resverlogix Corp. - Shareholder/Analyst Call
05-19	Resverlogix Closes US$2 Million Shares-for-Interest Private Placement	NE
05-15	Resverlogix : Financial Statement Q1 2026	PU
05-15	Resverlogix : MD&A Q1 2026	PU
05-15	Resverlogix Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-11	Resverlogix Corp. Announces One-Year Extension of USD 6.0 Million Secured Debenture with Shenzhen Hepalink Pharmaceutical Group Co., Ltd	CI
05-11	Resverlogix Announces One-Year Extension of Debenture	NE
04-16	Resverlogix Corp. Announces Filing of Annual Filings and Revocation of MCTO	NE
04-11	Resverlogix Corp. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04-10	Resverlogix : Annual Information Form 2025	PU
04-10	Resverlogix : Financial Statement Q4 2025	PU
04-09	Resverlogix Corp. Auditor Raises 'Going Concern' Doubt	CI
04-02	Resverlogix Corp. Announces Issuance of MCTO by ASC	NE
03-31	Resverlogix Corp. Provides Bi-Weekly MCTO Status Update	NE
03-17	Resverlogix Announces Delay in Filing of Annual Financial Statements, AIF, and MD&A	NE
02-18	Resverlogix Closes $2.8 Million Shares-for-Interest Private Placement	NE
11-19	Resverlogix Appoints Bradley Glass to Board of Directors	CI
11-18	Resverlogix Appoints Bradley Glass to Board of Directors	NE
11-13	Resverlogix : MD&A Q3 2025	PU
11-13	Resverlogix : Financial Statement September 30, 2025	PU
11-13	Resverlogix Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
25-08-14	Resverlogix : MD&A Q2 2025	PU
25-08-14	Resverlogix Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI